Literature DB >> 20360117

Breaking the cycle of medication overuse headache.

Stewart J Tepper1, Deborah E Tepper.   

Abstract

When patients who have frequent, disabling migraines take medications to relieve their symptoms, they run the risk that the attacks will increase in frequency to daily or near-daily as a rebound effect comes into play. This pattern, called medication overuse headache, is more likely to happen with butalbital and opioids than with migraine-specific drugs, as partial responses lead to recurrence, repeat dosing, and, eventually, overuse. Breaking the cycle involves weaning the patient from the overused medications, setting up a preventive regimen, and setting strict limits on the use of medications to relieve acute symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360117     DOI: 10.3949/ccjm.77a.09147

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  5 in total

Review 1.  Vertigo as a migraine phenomenon.

Authors:  Neil Cherian
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 2.  OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

3.  Neuroimaging and other investigations in patients presenting with headache.

Authors:  Callum W Duncan
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

4.  A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns.

Authors:  David J Muzina; William Chen; Steven J Bowlin
Journal:  Neuropsychiatr Dis Treat       Date:  2011-11-11       Impact factor: 2.570

5.  Banhabaekchulchunma-tang and chongsanggeontong-tang (herbal medicine) effect on migraine: A protocol for a systematic review of controlled trials.

Authors:  Jihye Seo; Cheol Hyun Kim; Hongmin Chu; Yeonju Moon; Sangkwan Lee
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.